34 related articles for article (PubMed ID: 12618754)
1. Prevalence of Her3 in gastric cancer and its association with molecular prognostic markers: a Saudi cohort based study.
Ahmed A
Libyan J Med; 2019 Dec; 14(1):1574532. PubMed ID: 30915908
[TBL] [Abstract][Full Text] [Related]
2. The significance of scirrhous gastric cancer cell lines: the molecular characterization using cell lines and mouse models.
Yashiro M; Matsuoka T; Ohira M
Hum Cell; 2018 Oct; 31(4):271-281. PubMed ID: 29876827
[TBL] [Abstract][Full Text] [Related]
3. Signet-ring Cells in the Skin: A Case of Late-onset Cutaneous Metastasis of Gastric Carcinoma and a Brief Review of Histological Approach.
Gündüz Ö; Emeksiz MC; Atasoy P; Kidir M; Yalçin S; Demirkan S
Dermatol Reports; 2016 Jun; 8(1):6819. PubMed ID: 28326183
[TBL] [Abstract][Full Text] [Related]
4. Exploring Missense Mutations in Tyrosine Kinases Implicated with Neurodegeneration.
Sami N; Kumar V; Islam A; Ali S; Ahmad F; Hassan I
Mol Neurobiol; 2017 Sep; 54(7):5085-5106. PubMed ID: 27544236
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical analysis of RTKs expression identified HER3 as a prognostic indicator of gastric cancer.
Ema A; Yamashita K; Ushiku H; Kojo K; Minatani N; Kikuchi M; Mieno H; Moriya H; Hosoda K; Katada N; Kikuchi S; Watanabe M
Cancer Sci; 2014 Dec; 105(12):1591-600. PubMed ID: 25455899
[TBL] [Abstract][Full Text] [Related]
6. Clinical management of advanced gastric cancer: the role of new molecular drugs.
De Vita F; Di Martino N; Fabozzi A; Laterza MM; Ventriglia J; Savastano B; Petrillo A; Gambardella V; Sforza V; Marano L; Auricchio A; Galizia G; Ciardiello F; Orditura M
World J Gastroenterol; 2014 Oct; 20(40):14537-58. PubMed ID: 25356019
[TBL] [Abstract][Full Text] [Related]
7. Role of epidermal growth factor receptor in acute and chronic kidney injury.
Tang J; Liu N; Zhuang S
Kidney Int; 2013 May; 83(5):804-10. PubMed ID: 23325080
[TBL] [Abstract][Full Text] [Related]
8. Molecular targeted therapies in advanced gastric cancer: does tumor histology matter?
Wong H; Yau T
Therap Adv Gastroenterol; 2013 Jan; 6(1):15-31. PubMed ID: 23320047
[TBL] [Abstract][Full Text] [Related]
9. Immunoregulatory protein profiles of necrotizing enterocolitis versus spontaneous intestinal perforation in preterm infants.
Chan KY; Leung FW; Lam HS; Tam YH; To KF; Cheung HM; Leung KT; Poon TC; Lee KH; Li K; Fok TF; Ng PC
PLoS One; 2012; 7(5):e36977. PubMed ID: 22606320
[TBL] [Abstract][Full Text] [Related]
10. Heregulin β-1 induces loss of cell-cell contact and enhances expression of MUC1 at the cell surface in HCC2998 and MKN45-1 cells.
Okoshi R; Shu CL; Ihara S; Fukui Y
PLoS One; 2011; 6(12):e29599. PubMed ID: 22216327
[TBL] [Abstract][Full Text] [Related]
11. EGF and TGF-β1 Effects on Thyroid Function.
Mincione G; Di Marcantonio MC; Tarantelli C; D'Inzeo S; Nicolussi A; Nardi F; Donini CF; Coppa A
J Thyroid Res; 2011; 2011():431718. PubMed ID: 21760980
[TBL] [Abstract][Full Text] [Related]
12. Genomic and epigenetic profiles of gastric cancer: potential diagnostic and therapeutic applications.
Yamashita K; Sakuramoto S; Watanabe M
Surg Today; 2011 Jan; 41(1):24-38. PubMed ID: 21191688
[TBL] [Abstract][Full Text] [Related]
13. Tumor-specific apoptosis caused by deletion of the ERBB3 pseudo-kinase in mouse intestinal epithelium.
Lee D; Yu M; Lee E; Kim H; Yang Y; Kim K; Pannicia C; Kurie JM; Threadgill DW
J Clin Invest; 2009 Sep; 119(9):2702-13. PubMed ID: 19690388
[TBL] [Abstract][Full Text] [Related]
14. Comparative study on overexpression of HER2/neu and HER3 in gastric cancer.
Zhang XL; Yang YS; Xu DP; Qu JH; Guo MZ; Gong Y; Huang J
World J Surg; 2009 Oct; 33(10):2112-8. PubMed ID: 19636613
[TBL] [Abstract][Full Text] [Related]
15. ERBBs in the gastrointestinal tract: recent progress and new perspectives.
Fiske WH; Threadgill D; Coffey RJ
Exp Cell Res; 2009 Feb; 315(4):583-601. PubMed ID: 19041864
[TBL] [Abstract][Full Text] [Related]
16. The ERBB3 receptor in cancer and cancer gene therapy.
Sithanandam G; Anderson LM
Cancer Gene Ther; 2008 Jul; 15(7):413-48. PubMed ID: 18404164
[TBL] [Abstract][Full Text] [Related]
17. Activation of ErbB3-PI3-kinase pathway is correlated with malignant phenotypes of adenocarcinomas.
Kobayashi M; Iwamatsu A; Shinohara-Kanda A; Ihara S; Fukui Y
Oncogene; 2003 Mar; 22(9):1294-301. PubMed ID: 12618754
[TBL] [Abstract][Full Text] [Related]
18. Muc4 is required for activation of ErbB2 in signet ring carcinoma cell lines.
Yokoyama A; Shi BH; Kawai T; Konishi H; Andoh R; Tachikawa H; Ihara S; Fukui Y
Biochem Biophys Res Commun; 2007 Mar; 355(1):200-3. PubMed ID: 17292332
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms behind signet ring cell carcinoma formation.
Fukui Y
Biochem Biophys Res Commun; 2014 Aug; 450(4):1231-3. PubMed ID: 25019985
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
